Requirement of phosphatase of regenerating liver-3 for the nucleolar localization of nucleolin during the progression of colorectal carcinoma

Cancer Science

Volumn 101, Issue 10, 2010, Pages 2254-2261

  Semba, Shuho ^a   Mizuuchi, Eri ^a   Yokozaki, Hiroshi ^a  

^a KOBE UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NUCLEOLIN; PHOSPHATASE OF REGENERATING LIVER 3; PROTEIN TYROSINE PHOSPHATASE; PROTEIN TYROSINE PHOSPHATASE INHIBITOR; UNCLASSIFIED DRUG; PHOSPHOPROTEIN; PTP4A3 PROTEIN, HUMAN; RNA BINDING PROTEIN; TUMOR PROTEIN;

ADULT; AGED; ARTICLE; CANCER GROWTH; CARCINOMA CELL; CELL CYCLE G2 PHASE; CELL CYCLE M PHASE; CELL CYCLE S PHASE; CELL GROWTH; CELL PROLIFERATION; COLORECTAL CARCINOMA; COMPARATIVE STUDY; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INHIBITION; FEMALE; GEL ELECTROPHORESIS; GENE OVEREXPRESSION; GENE SILENCING; GENETIC TRANSDUCTION; GENETIC TRANSFECTION; HUMAN; HUMAN CELL; IMMUNOPRECIPITATION; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MASS SPECTROMETRY; MITOSIS INHIBITION; NUCLEOLUS; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN LOCALIZATION; PROTEIN PROTEIN INTERACTION; RNA INTERFERENCE; UPREGULATION; WILD TYPE; CHEMISTRY; COLORECTAL TUMOR; DISEASE COURSE; MIDDLE AGED; PATHOLOGY; PHOSPHORYLATION; PHYSIOLOGY; TUMOR CELL LINE;

ADULT; AGED; CELL LINE, TUMOR; CELL NUCLEOLUS; CELL PROLIFERATION; COLORECTAL NEOPLASMS; DISEASE PROGRESSION; FEMALE; HUMANS; MALE; MIDDLE AGED; NEOPLASM PROTEINS; PHOSPHOPROTEINS; PHOSPHORYLATION; PROTEIN TYROSINE PHOSPHATASES; RNA-BINDING PROTEINS;

EID: 77957034951     PISSN: 13479032     EISSN: 13497006     Source Type: Journal    
DOI: 10.1111/j.1349-7006.2010.01651.x     Document Type: Article

References (30)

1. Saha S, Bardelli A, Buckhaults P. A phosphatase associated with metastasis of colorectal cancer. Science 2001, 294:1343-6.
2. Miskad UA, Semba S, Kato H, Yokozaki H. Expression of PRL-3 phosphatase in human gastric carcinomas: close correlation with invasion and metastasis. Pathobiology 2004, 71:176-84.
3. Kato H, Semba S, Miskad UA, Seo Y, Kasugai M, Yokozaki H. High expression of PRL-3 promotes cancer cell motility and liver metastasis in human colorectal cancer: a predictive molecular marker of metachronous liver and lung metastases. Clin Cancer Res 2004, 10:7318-28.
4. Wang L, Peng L, Dong B. Overexpression of phosphatase of regenerating liver-3 in breast cancer: association with a poor clinical outcome. Ann Oncol 2006, 17:1517-22.
5. Polato F, Codegoni A, Fruscio R. PRL-3 phosphatase is implicated in ovarian cancer growth. Clin Cancer Res 2005, 11:6835-9.
6. Wu X, Zeng H, Zhang X. Phosphatase of regenerating liver-3 promotes motility and metastasis of mouse melanoma cells. Am J Pathol 2004, 164:2039-54.
7. Fiordalisi JJ, Keller PJ, Cox AD. PRL tyrosine phosphatases regulate rho family GTPases to promote invasion and motility. Cancer Res 2006, 66:3153-61.
8. Wang H, Quah SY, Dong JM, Manser E, Tang JP, Zeng Q. PRL-3 down-regulates PTEN expression and signals through PI3K to promote epithelial-mesenchymal transition. Cancer Res 2007, 67:2922-6.
9. Peng L, Jin G, Wang L, Guo J, Meng L, Shou C. Identification of integrin α1 as an interacting protein of protein tyrosine phosphatase PRL-3. Biochem Biophys Res Commun 2006, 342:179-83.
10. Forte E, Orsatti L, Talamo F, Barbato G, De Francesco R, Tomei L. Ezrin is a specific and direct target of protein tyrosine phosphatase PRL-3. Biochim Biophys Acta 2008, 1783:334-44.
11. Mizuuchi E, Semba S, Kodama Y, Yokozaki H. Down-modulation of keratin 8 phosphorylation levels by PRL-3 contributes to colorectal carcinoma progression. Int J Cancer 2009, 124:1802-10.
12. Ahn JH, Kim SJ, Park WS. Synthesis and biological evaluation of rhodanine derivatives as PRL-3 inhibitors. Bioorg Med Chem Lett 2006, 16:2996-9.
13. Zeng Q, Dong JM, Cuo K. PRL-3 and PRL-1 promote cell migration, invasion, and metastasis. Cancer Res 2003, 63:2716-22.
14. General Rules for Clinical and Pathological Studies on Cancer of the Colon, Rectum and Anus 2009, Japanese Society for Cancer of the Colon and Rectum, 7th edn, Tokyo, Kanehara Ltd
15. Mongelard F, Bouvet P. Nucleolin: a multiFACeTed protein. Trends Cell Biol 2007, 17:80-6.
16. Polesskaya A, Cuvellier S, Nagibneva I, Duquet A, Moss EG, Harel-Bellan A. Lin-28 binds IGF-2 mRNA and participates in skeletal myogenesis by increasing translation efficiency. Genes Dev 2007, 21:1125-38.
17. Uley PG, Nestler EJ. Regulation of ΔFosB transcriptional activity by Ser27 phosphorylation. Eur J Neurosci 2007, 25:224-30.
18. Warrener P, Petryshyn R. Phosphorylation and proteolytic degradation of nucleolin from 3T3-F442A cells. Biochem Biophys Res Commun 1991, 180:716-23.
19. Baldeli A, Saha S, Sager JA. PRL-3 expression in metastatic cancers. Clin Cancer Res 2003, 9:5607-15.
20. Bugler B, Caizergues-Ferrer M, Bouche G, Bourbon H, Amalric F. Detection and localization of a class of proteins immunologically related to a 100-kDa nucleolar protein. Eur J Biochem 1982, 128:475-80.
21. Erard MS, Belenguer P, Caizergues-Ferrer M, Oantaloni A, Amalric F. A major nucleolar protein, nucleolin, induces chromatin decondensation by binding to histone H1. Eur J Biochem 1988, 175:525-30.
22. Bugler B, Bourbon H, Lapeyre B. RNA binding fragments from nucleolin contain the ribonucleoprotein consensus sequence. J Biol Chem 1987, 262:10922-5.
23. Borer RA, Lehner CF, Eppenberger HM, Nigg EA. Major nucleolar proteins shuttle between nucleus and cytoplasm. Cell 1989, 56:379-90.
24. Belenguer P, Caizergues-Ferrer M, Labbe JC, Doree M, Amalric F. Mitosis-specific phosphorylation of nucleolin by p34cdc2 protein kinase. Mol Cell Biol 1990, 10:3607-18.
25. Peter M, Nakagawa J, Doree M, Labbe JC, Nigg EA. Identification of major nucleolar proteins as candidate mitotic substrates of cdc2 kinase. Cell 1990, 60:791-801.
26. Liang F, Kumar S, Zhang ZY. Proteomic approaches to studying protein tyrosine phosphatases. Mol Biosyst 2007, 3:308-16.
27. Stephens BJ, Han H, Gokhale V, Von Hoff DD. PRL phosphatases as potential molecular targets in cancer. Mol Cancer Ther 2005, 4:1653-61.
28. Sengupta TK, Bandyopadhyay S, Fernandes DJ, Spicer EK. Identification of nucleolin as an AU-rich element binding protein involved in bcl-2 mRNA stabilizaion. J Biol Chem 2004, 279:10855-63.
29. Liston P, Fong WG, Korneluk RG. The inhibitors of apoptosis: there is more to life than Bcl2. Oncogene 2003, 22:8568-80.
30. Valassiadou KE, Stefanaki K, Tzardi M. Immunohistochemical expression of p53, bcl-2, mdm2 and waf1/p21 proteins in colorectal adenocarcinomas. Anticancer Res 1997, 17:2571-6.